| ID | Name | CAS | Data |
MW (g/mol) |
| 33-724-1 |
2-(3-Oxo-1,3-dihydro-2-benzofuran-1-yl)-1h-isoindole-1,3(2h)-dione
|
|
2 | 279.25 |
| 33-826-8 |
5«alpha»-Androstane-3«alpha»,16«alpha»,17«beta»-triol, TMS
|
|
2 | 525.00 |
| 33-903-2 |
9H-Purine-9-acetic acid, 6-[(p-chlorophenyl)amino)-, ethyl ester
|
101103-22-4 |
2 | 331.76 |
| 34-040-9 |
5-«beta»-Pregnan-3-«beta»,11-«beta»-diol-20-one, MO-TMS
|
|
2 | 507.90 |
| 34-113-8 |
3«alpha»,12«alpha»-Dihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl ether
|
|
2 | 639.14 |
| 34-237-1 |
3-Methyl-L-histidine, N-(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
|
2 | 397.71 |
| 34-293-9 |
L-(+)-Lactic acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
2 | 318.60 |
| 34-422-5 |
1,2,4-Triazol-5(4H)-thione, 4-allyl-3-phenyl-
|
|
2 | 217.30 |
| 34-539-6 |
2-hydroxy-1,4-benzoxazin-3-one, N,O-bistrimethylsilyl
|
|
2 | 309.51 |
| 34-562-0 |
N,n'-diacetyl-n,n'-bis-[5-chloro-1,3,4-thiadiazolyl-2-]hydrazine
|
|
2 | 353.22 |
| 34-614-2 |
allo-5B-Pregnan-3A,11B,21-triol-20-one, MO TMS
|
|
2 | 596.08 |
| 34-631-3 |
5«alpha»-Androstan-17«alpha»-methyl-4«beta»,17«beta»-diol-3,2c-pyrazol, TMS
|
|
2 | 488.85 |
| 34-680-9 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-4.«alpha»,17«beta»-diol, bisTMTBS
|
|
2 | 585.06 |
| 34-885-2 |
Bolasterone M (5B-Androstan-7A,17A-dimethyl-3A,17B-diol), TMS
|
|
2 | 464.87 |
| 34-907-7 |
5-«beta»-Pregnan-3-«beta»,11-«beta»,20-«alpha»-triol, TMS
|
|
2 | 553.05 |
| 34-912-1 |
Urea, 1-(2-chloroethyl)-1-nitroso-3-(tetrahydrothiopyran-4-yl)-
|
33022-01-4 |
2 | 251.73 |
| 34-914-9 |
Silica-1,3,5,8-tetramethyl-2,4,6,7-tetraethylporphyrine complex, bis-OTMS
|
|
2 | 685.13 |
| 34-939-2 |
4'-Hydroxystanozolol (5A-Androstan-17A-methyl-4',17B-diol-3,2c-pyrazol), TMS
|
|
2 | 488.85 |
| 34-969-9 |
1-Aza-5-boratricyclo[3.3.3.01,5]undecane
|
|
2 | 151.06 |
| 35-001-1 |
Silane, dimethyl(2,6-dimethylnon-1-en-3-yn-5-yloxy)dodecyloxy-
|
|
2 | 408.74 |
| 35-181-2 |
Nicotinonitrile, 2-hydroxy-6-methyl-5-nitro-4-(trifluoromethyl)-, (keto form)
|
|
2 | 247.13 |
| 35-186-7 |
5«beta»-pregnane-3«alpha»,17«alpha»,20«beta»-triol, 3,17,20-tris-TMS
|
|
2 | 553.05 |
| 35-260-4 |
L-Selenomethionine, N(O,S)-ethoxycarbonyl, (S)-(+)-3-methyl-2-butyl ester
|
|
2 | 338.30 |
| 35-314-4 |
(3R)-3-Methyl-1,4-bis(trimethylsilyl)piperazine-2,5-dione
|
|
2 | 272.49 |
| 35-317-1 |
3,16,20-Tris[(trimethylsilyl)oxy]-5.alpha-pregnane, (3«beta»,16«alpha»,20«alpha»)-
|
33287-36-4 |
2 | 553.05 |
| 35-320-7 |
5-«alpha»-Pregnan-20-«beta»-ol-11-one, MO-TMS
|
|
2 | 419.72 |
| 35-413-4 |
3«alpha»,5«beta»,12«alpha»-trihydroxy-5«beta»-cholan-24-oic acid, TMS
|
|
2 | 697.30 |
| 35-419-8 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-4.«alpha»,17«alpha»-diol, bisTMTBS
|
|
2 | 585.06 |
| 35-437-8 |
Silane, diphenyldi(1,1,1-trifluoro-3-bromoprop-2-yloxy)-
|
|
2 | 566.21 |
| 35-468-4 |
4-Chloro-N-(2-hydroxypropionyl)-benzenesulfonamide, N,O-di(tert.-butyldimethylsilyl)-
|
|
2 | 492.22 |
| 35-469-3 |
4-Pyridoxic acid, bis(tert-butyldimethylsilyl) ether, tert-butyldimethylsilyl ester
|
|
2 | 525.94 |
| 35-513-3 |
myo-Inositol, 1,2,3,4,5,6-hexakis-O-(trimethylsilyl)-
|
|
2 | 613.25 |
| 35-587-2 |
5-Chloro-1H-indole-2-carboxylic acid, tert-butyldimethylsilyl ester
|
|
2 | 309.87 |
| 35-604-2 |
Oxadiazole, 1,2,4-, 3-(morpholinomethyl)-5-(5-nitrofuran-2-yl)-
|
36133-75-2 |
2 | 280.24 |
| 35-775-3 |
5.alpha.-Stigmast-8(14)-en-3.beta.-ol, TMS
|
|
2 | 486.90 |
| 35-781-6 |
Methyl 5-.beta.-cholan-3,12-dione-24-oate, oxime, TMS
|
|
2 | 576.97 |
| 35-820-2 |
[(2-Ethyl-5-methylfuran-3,4-diyl)bis(oxy)]bis(trimethylsilane)
|
|
2 | 286.52 |
| 35-843-7 |
5-«alpha»-Pregnan-3-«beta»-ol-11-one, MO-TMS
|
|
2 | 419.72 |
| 35-880-6 |
cis-Phenanthrene, 9,10-dihydro-9-methyl-9,10-diol, butylboronate
|
|
2 | 292.18 |
| 35-936-4 |
4-Aminobenzoic acid, N- trifluoroacetyl -, N,O-bis(tert.-butyldimethylsilyl)-
|
|
2 | 461.67 |
| 35-964-3 |
2-(2,2-Dimethylpentoxy)-3-methyl-6-(n-heptyl) pyrazine
|
116660-34-5 |
2 | 306.49 |
| 35-996-8 |
1,3,5(10)-Oestratriene-2-methoxy-3,16«alpha»,17«beta»-triol, 3-TMS-16,17-PFP
|
|
2 | 682.62 |
| 35-998-6 |
S-triazine], 2,2'-cyclobut-1,2-ylene-bis[4,6-diamino-
|
19438-85-8 |
2 | 274.29 |
| 36-039-9 |
9H-purine, 2,6-difluoro-9-beta-d-xylofuranosyl-, 2',3',5'-triacetate
|
18354-15-9 |
2 | 414.32 |
| 36-045-2 |
ent-7-«alpha»,12-«beta»-Dihydroxykaurenonic acid, methyl ester, TMS
|
|
2 | 492.84 |
| 36-074-0 |
Silane, dimethyl(2,2,3,3,4,4,5,5-octafluoropentyloxy)pentyloxy-
|
|
2 | 376.36 |
| 36-246-9 |
3«beta»,17«beta»-Dihydroxy-5«alpha»-androstan-6-one, TMS
|
|
2 | 450.80 |
| 36-280-1 |
[(2-Ethyl-5-methylfuran-3,4-diyl)bis(oxy)]bis[tert-butyl(dimethyl)silane]
|
|
2 | 370.68 |
| 36-437-7 |
5-«beta»-Pregnan-3-«alpha»20-«beta»-diol-11-one, MO-TMS
|
|
2 | 507.90 |
| 36-670-8 |
5«alpha»-Androstane-3«beta»,7«alpha»,17«beta»-triol, TMS
|
|
2 | 525.00 |
| 36-697-9 |
5«alpha»-Androstane-3«alpha»,11«beta»,17«beta»-triol, TMS
|
|
2 | 525.00 |
| 36-725-7 |
N-(4-Morpholin-4-yl-phenyl)-2-nitro-benzenesulfonamide, N-trimethylsilyl-
|
|
2 | 435.57 |
| 36-745-5 |
4-Pregnen-3-«beta»,20-«alpha»-diol-11-one, MO-TMS
|
|
2 | 505.88 |
| 36-790-5 |
tert-Butyl-[2-[2-[2-[2-(tert-butyldimethylsilyl)oxyethoxy]ethoxy]ethoxy]ethoxy]dimethylsilane
|
|
2 | 422.75 |
| 36-819-3 |
cis-Phenanthrene, 9,10-dihydro-9-methyl-9,10-diol, 3,4-dimethoxy, bis-TMS
|
|
2 | 430.68 |
| 36-838-2 |
3«alpha»,7«alpha»,12«beta»-Trihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl ether
|
|
2 | 639.14 |
| 36-842-7 |
5«alpha»-Androst-16-en-3«beta»-ol trimethylsilyl ether
|
56210-81-2 |
2 | 346.62 |
| 36-898-6 |
1,1,1-trimethyl-N-((2E)-1-methyl-3-(trimethylsilyl)-4-[(trimethylsilyl)oxy]-1,3-dihydro-2H-imidazol-2-ylidene)silanamine
|
|
2 | 329.66 |
| 37-008-2 |
Ethyl 6-amino-4-chloro-5-nitro-2-pyridinyl(benzyl)carbamate
|
116403-17-9 |
2 | 350.76 |
| 37-022-6 |
5-«beta»-Pregnane-3«beta», 16«alpha», 20«alpha»-triol, MO TMS
|
|
2 | 553.05 |
| 37-204-4 |
Benzoic acid, 2-hydroxy-5-methyl-3-(1,1-dimethylethyl), DTBS
|
|
2 | 348.55 |
| 37-269-3 |
9H-purine-6(1h)-thione, 2-amino-9-beta-d-ribofuranosyl-, 2',3',5'-tribenzoate
|
|
2 | 611.64 |
| 37-309-8 |
2,2,4,4,6,6,8,10-octamethyl-8,10-diphenyl-[1,3,5,7,9,2,4,6,8,10]cyclopentasiloxane
|
|
2 | 494.92 |
| 37-554-6 |
5-«alpha»-Pregnane-3-«beta»,17-«alpha»,20-«alpha»-triol, tris-TMS
|
|
2 | 553.05 |
| 37-563-6 |
5-(3',3'-Dibutyl-1'-triazeno)-1,2,3-triazole-4-carboxamide
|
4342-10-3 |
2 | 267.33 |
| 37-587-0 |
13,14-Dihydro-15-keto-PGE2, EO-TMS, isomer # 3
|
|
2 | 582.96 |
| 37-595-1 |
5«alpha»-Androst-1-ene-3,17-dione, per-TMS
|
|
2 | 430.77 |
| 37-631-0 |
5«alpha»-Androstane-3«beta»,6«beta»,17«beta»-triol, TMS
|
|
2 | 525.00 |
| 37-741-8 |
Urea, 1-(2-hydroxyethyl)-1-nitroso-3-(1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinyl)-
|
|
2 | 243.18 |
| 37-754-4 |
Silane, dimethyl(dimethyl(2,2,2-trichloroethoxy)silyloxy)(2,2,2-trichloroethoxy)-
|
|
2 | 429.10 |
| 37-800-2 |
5-Pregnan-11-one, 3«alpha»,20«alpha»,21-trihydroxy, MO-TMS
|
|
2 | 596.08 |
| 37-830-9 |
4-Pyrimidinecarboxylic acid, 5-amino-1,2,3,6-tetrahydro-2,6-dioxo-
|
7164-43-4 |
2 | 171.11 |
| 37-834-5 |
3«alpha»,7«alpha»,17«alpha»-trihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
2 | 753.40 |
| 37-835-4 |
5«beta»-Androstan-3«alpha»,11«beta»-diol-17-one (Androsterone), MO-3,11-bis-TMS
|
|
2 | 479.84 |
| 37-894-9 |
ent-7-«alpha»,12-«alpha»-Dihydroxykaurenonic acid, methyl ester, TMS
|
|
2 | 492.84 |
| 37-917-3 |
5-«beta»-Cholestan-3-«beta»,7-«alpha»,12-«alpha»,26-tetrol, TMS
|
|
2 | 725.39 |
| 37-925-4 |
Uridine, 2'-O-TBDMS, 3'-O-acetyl, 5'-O-TBDMS
|
|
2 | 514.76 |
| 37-961-4 |
5«beta»-Androstan-17«alpha»-methyl-3«alpha»,17«beta»-diol, TMS
|
|
2 | 450.85 |
| 38-020-7 |
(3R)-trans-Dihydro-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-2(3H)-furanone diTMS
|
102907-87-9 |
2 | 502.75 |
| 38-072-0 |
3«alpha»,7«alpha»,12«alpha»-trihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
2 | 753.40 |
| 38-112-5 |
GA20 opened lactone-1(10)-ene, methyl ester TMS ether
|
|
2 | 432.63 |
| 38-288-1 |
24-Nor-5B-cholestane-3A,7A,12A,25-tetrol, TMS
|
|
2 | 711.37 |
| 38-364-6 |
5«beta»-Pregnane, 3«alpha»,11«beta»,17,20«alpha»,21-pentakis(trimethylsiloxy)-
|
32213-62-0 |
2 | 729.41 |
| 38-435-7 |
3«alpha»,7«alpha»,12«alpha»,24-tetrahydroxy-5««beta»'»-C27-bile acid, methyl ester, TMS
|
|
2 | 769.40 |
| 38-516-7 |
Silane, dimethyl(2,6-dimethylnon-1-en-3-yn-5-yloxy)nonyloxy-
|
|
2 | 366.65 |
| 38-617-5 |
Silane, dimethyl(dimethyl(dimethyl(3,5-difluorophenoxy)silyloxy)silyloxy)(3,5-difluorophenoxy)-
|
|
2 | 464.63 |
| 38-628-3 |
Silane, dimethyl(2,6-dimethylnon-1-en-3-yn-5-yloxy)decyloxy-
|
|
2 | 380.68 |
| 38-734-5 |
O18-2-hydroxy-1,4-benzoxazin-3-one, N,O-bistrimethylsilyl
|
|
2 | 309.51 |
| 38-749-9 |
1H-Indole, 1-(trimethylsilyl)-5-[(trimethylsilyl)oxy]-3-[2-[(trimethylsilyl)oxy]ethyl]-
|
|
2 | 393.75 |
| 38-768-8 |
2-tert-Butyldimethylsilyl-3-(tert-butyldimethylsilyl)amino-1,2,4-triazole
|
|
2 | 312.61 |
| 38-775-0 |
3.beta.-Hydroxy-5.alpha.-androstane-6,17-dione, TMS
|
|
2 | 448.80 |
| 38-856-0 |
1,3-Disiloxane, 1,3-bis-ethenyl, 1,3-bis-(chloromethyl), 1,3-bis-(2-propenyl)
|
|
2 | 307.36 |
| 38-902-8 |
Planteose: aD-Galp(1->6)-bDFruf(2->1)-aGlu, oxime-TMS
|
|
2 | 1282.43 |
| 38-927-1 |
L-Tyrosine, N,O-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
107716-01-8 |
2 | 523.97 |
| 39-029-7 |
Silane, diphenyl(2,2,3,4,4,4-hexafluorobutoxy)pentyloxy-
|
|
2 | 450.49 |
| 39-271-8 |
Methyl 4-(2«lambda»5-1,2-triazadienyl)-1h-imidazole-5-carboxylate
|
|
2 | 167.13 |
| 39-283-5 |
Pentanoic acid, 2-[(tert-butyldimethylsilyl)oxy]-4-methyl-, tert-butyldimethylsilyl ester
|
|
2 | 360.69 |
| 39-359-1 |
N6-TMS-2'-Deoxyadenosine, 3'-O-TMS, 5'-O-TBDMS
|
|
2 | 509.87 |
| 39-421-1 |
Benzaldehyde, 2-hydroxy, 3,5-bis-tert.-butyl, oxime, TMS
|
|
2 | 393.71 |
| 39-467-1 |
(Z)-10-Dodecenoic acid, 9,12-dioxo, methyl ester, «omega»-PFB-oxime, TMS-enol, # 2
|
|
2 | 507.57 |
|
« Previous Results
Next Results »
|